The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism
Abstract
We recently reported that estrogen exerts distinct effects on the GH/IGF-1 axis that are dependent on the route of delivery, probably reflecting a first-pass effect on hepatic IGF-1 production. Oral administration reduces IGF-1 and increases GH levels; transdermal administration elevates IGF-1 without changing GH concentrations. Since mesenchymal tissue is a target for GH and IGF-1 action, we studied changes in the GH/IGF-1 axis following oral (ethinyl estradiol, 20 μg/day) versus transdermal (Estraderm 100 TTS, Ciba Geigy, 100 μg 17β-estradiol per day) estrogen delivery and compared corresponding effects on connective and bone tissue metabolism. Mean 24 h GH levels, IGF-1, markers of fibroblast (procollagen III) and osteoblast (procollagen I, osteocalcin) function, and indices of bone turnover (fasting urinary hydroxyproline and calcium to creatinine ratios, UOHPr/Cr and UCa/Cr) were measured before and after 2 months of either oral or transdermal therapy in two groups of postmenopausal women. Transdermal estrogen administration significantly (p < 0.05) increased IGF-1, procollagen III, procollagen I, osteocalcin, and UOHPr/Cr. In contrast, oral estrogen administration had a suppressive effect; the levels of IGF-1 (p = 0.001), procollagen III (p = 0.018), procollagen I (p = 0.002), osteocalcin (p = 0.015), and UOHPr/Cr (p = 0.004) were significantly different from those measured during transdermal administration. Both treatments significantly reduced UCa/Cr (p < 0.015). IGF-1 changes during estrogen therapy were significantly related (p < 0.05) to changes in procollagen III, procollagen I, osteocalcin, and UOHPr/Cr. Transdermally delivered estrogen stimulates IGF-1 production, increases osteoblastic function, and stimulates bone and nonbone collagen synthesis. When delivered orally, estrogen reduces IGF-1 and inhibits osteoblastic function; both routes suppress urinary calcium loss. Estrogen administration confers distinct route-dependent effects on connective and bone tissue metabolism; the specific effects on fibroblast and osteoblast function suggest IGF-1 dependency. The divergent effects on indices of bone turnover and connective tissue metabolism suggest that the route of estrogen replacement therapy may have different effects on the integrity of structural tissue in the menopause.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Evidence of Estrogen Receptors in Normal Human Osteoblast-Like Cells
Eriksen, E. F., Colvard, D. S., Berg, N. J., Graham, M. L., Mann, K. G., Spelsberg, T. C., & Riggs, B. L. (1988) · Science · doi:10.1126/science.3388021 · Cited by 1,229
HO, K. Y., EVANS, W. S., BLIZZARD, R. M., VELDHUIS, J. D., MERRIAM, G. R., SAMOJLIK, E., FURLANETTO, R., ROGOL, A. D., KAISER, D. L., & THORNER, M. O. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-51 · Cited by 921
Self-citationInsulin-Like Growth Factor I Has Independent Effects on Bone Matrix Formation and Cell Replication*
HOCK, J. M., CENTRELLA, M., & CANALIS, E. (1988) · Endocrinology · doi:10.1210/endo-122-1-254 · Cited by 597
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
Self-citationRadioimmunoassay of the carboxyterminal propeptide of human type I procollagen
Melkko, J., Niemi, S., Risteli, L., & Risteli, J. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.7.1328 · Cited by 513
Biologic Effects of Transdermal Estradiol
Chetkowski, R. J., Meldrum, D. R., Steingold, K. A., Randle, D., Lu, J. K., Eggena, P., Hershman, J. M., Alkjaersig, N. K., Fletcher, A. P., & Judd, H. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142505 · Cited by 468
Biologic effects of transdermal estradiol
Chetkowski, R., Meldrum, D., & Steingold, K. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90325-0 · Cited by 467
Mode of Action of Pituitary Growth Hormone on Target Cells
Isaksson, O. G. P., Eden, S., & Jansson, J. (1985) · Annual Review of Physiology · doi:10.1146/annurev.ph.47.030185.002411 · Cited by 447
A Specific Growth Hormone-Binding Protein in Human Plasma: Initial Characterization*
BAUMANN, G., STOLAR, M. W., AMBURN, K., BARSANO, C. P., & DEVRIES, B. C. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-134 · Cited by 426
Cited by
Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 855
“How- ever,serumosteocalcindidnotchangeinwomenreceiving estrogentherapyandincreasedonlyinthosewithoutestro- gentreatment(107)suggesting,inconcordancewiththedata byHoandWeissberger(342)describedabove,thathepatic IGF-Igenerationwassuppressedduetooraldeliveryof estrogen.”
BackgroundTURNER, R. T., RIGGS, B. L., & SPELSBERG, T. C. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-275 · Cited by 754
Estrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
“The markers of connective and bone tissue metabolism are influenced by the route of estrogen treatment (143).”
BackgroundSelf-citationEndocrine consequences of anorexia nervosa
Misra, M., & Klibanski, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70180-3 · Cited by 341
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
Locatelli, V., & Bianchi, V. E. (2014) · International Journal of Endocrinology · doi:10.1155/2014/235060 · Cited by 307
“The women receiving estrogen therapy showed a less increment of all bone markers [244] suggesting, in concordance with the data from Ho and Weissberger [259], that hepatic IGF1 generation was suppressed due to oral delivery of estrogen.”
Metadata
- Authors
- Dr. Ho, K. K. Y., & Weissberger, A. J.
- Affiliations
- Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, New South Wales, Australia
- Garvan Institute of Medical Research (AU)
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-07-01
- Volume
- 7
- Issue
- 7
- Pages
- 821-827
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2048218850
- Cited by
- 91
- References
- 46
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council of Australia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- estrogen, transdermal estrogen, oral estrogen, ethinyl estradiol, growth hormone, insulin-like growth factor I, somatotropic axis, bone turnover, osteoblast activity, collagen synthesis, type III procollagen, osteocalcin, urinary hydroxyproline, urinary calcium, postmenopausal women, route of administration, hepatic first-pass metabolism
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Bone and Bones, Collagen, Connective Tissue, Estradiol, Ethinyl Estradiol, Female, Fibroblasts, Follicle Stimulating Hormone, Humans, Insulin-Like Growth Factor I, Luteinizing Hormone, Middle Aged, Osteoblasts, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. https://app.cochat.ai/papers/10.1002/jbmr.5650070711
- The paper
- Dr. Ho, K. K. Y., & Weissberger, A. J. (1992). Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650070711
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.